At 36.8x earnings and 26.9x forward earnings, the market is pricing AME as a premium compounder despite a modest 5.50% ROE and a stretched 6.1 forward PEG, which signals growth expectations that are rich relative to near-term expansion. However, the balance sheet is undeniably strong, with an Altman Z-Score of 7.9 indicating very low bankruptcy risk and financial stability well above distress thresholds. A 12.50% ROIC against a 13.90% operating margin suggests the business is productive but not extraordinary at this valuation multiple. This is not a distressed mispricing; it is a quality industrial trading at a growth multiple that leaves little room for operational slippage. The stock is safe, but safety is already priced in.